CONSOLIDATED STATEMENT OF CASH FLOWS (USD $)	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Cash flows from operating activities:
Net income attributable to Honeywell	$ 966,000,000	$ 823,000,000
Adjustments to reconcile net income attributable to Honeywell to net cash provided by operating activities:
Depreciation and amortization	248,000,000	230,000,000
Repositioning and other charges	128,000,000	122,000,000
Net payments for repositioning and other charges	(98,000,000)	(104,000,000)
Pension and other postretirement expense	1,000,000	36,000,000
Pension and other postretirement benefit payments	(171,000,000)	(289,000,000)
Stock compensation expense	54,000,000	51,000,000
Deferred income taxes	27,000,000	132,000,000
Excess tax benefits from share based payment arrangements	(24,000,000)	(12,000,000)
Other	(33,000,000)	(7,000,000)
Changes in assets and liabilities, net of the effects of acquisitions and divestitures:
Accounts, notes and other receivables	(142,000,000)	(40,000,000)
Inventories	(51,000,000)	(108,000,000)
Other current assets	18,000,000	(28,000,000)
Accounts payable	(295,000,000)	(203,000,000)
Accrued liabilities	(287,000,000)	(407,000,000)
Net cash provided by operating activities	341,000,000	196,000,000
Cash flows from investing activities:
Expenditures for property, plant and equipment	(148,000,000)	(152,000,000)
Proceeds from disposals of property, plant and equipment	0	1,000,000
Increase in investments	(174,000,000)	(84,000,000)
Decrease in investments	166,000,000	92,000,000
Cash paid for acquisitions, net of cash acquired	(122,000,000)	(1,000,000)
Other	(33,000,000)	22,000,000
Net cash used for investing activities	(311,000,000)	(122,000,000)
Cash flows from financing activities:
Net increase in commercial paper	800,000,000	349,000,000
Net increase in short-term borrowings	8,000,000	7,000,000
Proceeds from issuance of common stock	164,000,000	90,000,000
Proceeds from issuance of long-term debt	7,000,000	2,000,000
Payments of long-term debt	(600,000,000)	0
Excess tax benefits from share based payment arrangements	24,000,000	12,000,000
Repurchases of common stock	(139,000,000)	0
Cash dividends paid	(322,000,000)	(291,000,000)
Net cash (used for)/provided by financing activities	(58,000,000)	169,000,000
Effect of foreign exchange rate changes on cash and cash equivalents	(67,000,000)	47,000,000
Net (decrease)/increase in cash and cash equivalents	(95,000,000)	290,000,000
Cash and cash equivalents at beginning of period	4,634,000,000	3,698,000,000
Cash and cash equivalents at end of period	$ 4,539,000,000	$ 3,988,000,000